Alamos Gold : MANAGEMENT INFORMATION CIRCULAR - Form 6-K
5 of 5 Overall Attendance: 100% Other Public Boards N/A ... | April 19, 2023
Source: marketscreener.com
Page 5 - Expansion Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Expansion Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Expansion Study Today - Breaking & Trending Today
Alamos Gold Reports Record Fourth Quarter 2022 Production
Strong outlook with multi-year production guidance increased, capital guidance maintained, and all-in sustaining costs expected to decrease 18% over the...
Source: globenewswire.com
Merck to Present Data From Its Hematology Portfolio and Promising Pipeline at the 64th American Soci
Presentations include new data on investigational medicines – favezelimab (MK-4280), zilovertamab vedotin (MK-2140) and nemtabrutinib (MK-1026) – as well as KEYTRUDA® (pembrolizumab) in multiple blood cancersRAHWAY, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Ca...
Source: pharmiweb.com
Merck to Present Data From Its Hematology Portfolio and Promising Pipeline at the 64th American Society of Hematology (ASH) Annual Meeting
01.12.2022 - Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the presentation of findings from clinical trials and real-world studies at the upcoming 64th American Society of Hematology (ASH) Annual Meeting from Dec. ...
Source: wallstreet-online.de
Adagene Announces Poster Presentations on Anti-CTLA-4 NEObody, ADG116, at Upcoming Society for Immunotherapy of Cancer's (SITC) Annual Meeting in November Seite 1
11.10.2022 - - NEObody technology platform enables dynamic targeting of a distinct epitope of CTLA-4 for enhanced safety and efficacy - - Data from phase 1b/2 studies in heavily pre-treated patients showcase differentiated safety profile of ... Seite 1
Source: wallstreet-online.de